📰 Jeff Boyle News
Jeff Boyle News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Jeff Boyle. Real-time updates on events, politics, business and more.
June 3, 2024
NEW HAVEN, Conn., June 03, 2024 -- Arvinas, Inc. , a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will...
May 18, 2024
The four bison cows, with their three new calves as of this spring. Photo by Cristina Jann
May 16, 2024
The four bison cows, with their three new calves as of this spring. Photo by Cristina Jann
May 2, 2024
NEW HAVEN, Conn., May 02, 2024 -- Arvinas, Inc. , a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will...
April 10, 2024
By BECKY KISERHays PostThe existing turf at Hays' Larks Park was inst
April 5, 2024
Hays city commissioners at their April 4 work session. Photo by Becky Kiser/Hays Post
February 20, 2024
- Sean Cassidy leaving Arvinas as of February 29, 2024 - - Randy Teel, Ph.D. to assume the role of interim Chief Financial Officer - NEW HAVEN, Conn., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (NASDAQ:ARVN), a
February 6, 2024
-- Vepdegestrant is an investigational PROteolysis Targeting Chimera (PROTAC®) protein degrader designed to target and degrade the estrogen receptor (ER)...
February 6, 2024
-- Vepdegestrant is an investigational PROteolysis Targeting Chimera protein degrader designed to target and degrade the estrogen receptor protein -- NEW HAVEN, Conn. and NEW YORK, Feb. 06, 2024 ...
February 6, 2024
-- Vepdegestrant is an investigational PROteolysis Targeting Chimera (PROTAC®) protein degrader designed to target and degrade the estrogen receptor (ER) protein --